InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-1.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Amman Bradford K., 首席财务官. Director active across 1 company, notably Vivos Therapeutics, Inc.. Aggregated, 2 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €4k. Activity tracked since 25 May 2021. The latest transaction was disclosed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Amman Bradford K.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
250,000 股@ US$0.41Common StockSEC:0001493152-26-040238:0
1,000 股@ US$5.29100.0% 占其流量Common StockSEC:0001493152-21-012902:0
标准退出：2021年8月23日 (T+90)
2 条申报中的 2 条
About Amman Bradford K.
Bradford K. Amman is the Chief Financial Officer at Vivos Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the financial health and sustainable growth of the organization.
